vs
NAPCO SECURITY TECHNOLOGIES, INC（NSSC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
NAPCO SECURITY TECHNOLOGIES, INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.4倍（$48.2M vs $35.5M），NAPCO SECURITY TECHNOLOGIES, INC净利率更高（28.0% vs -304.2%，领先332.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 12.2%），NAPCO SECURITY TECHNOLOGIES, INC自由现金流更多（$14.5M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -1.1%）
纳普科安全技术公司1969年成立，总部位于纽约阿米蒂维尔，核心业务为研发生产各类安全产品，包括电子锁具、安防警报系统以及楼宇出入管控系统，曾用名纳普科安全系统公司。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
NSSC vs RXRX — 直观对比
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.2M | $35.5M |
| 净利润 | $13.5M | $-108.1M |
| 毛利率 | 58.6% | 59.8% |
| 营业利润率 | 30.6% | -304.8% |
| 净利率 | 28.0% | -304.2% |
| 营收同比 | 12.2% | 681.7% |
| 净利润同比 | 29.0% | 39.6% |
| 每股收益（稀释后） | $0.38 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $48.2M | $35.5M | ||
| Q3 25 | $49.2M | $5.2M | ||
| Q2 25 | $50.7M | $19.2M | ||
| Q1 25 | $44.0M | $14.7M | ||
| Q4 24 | $42.9M | $4.5M | ||
| Q3 24 | $44.0M | $26.1M | ||
| Q2 24 | $50.3M | $14.4M | ||
| Q1 24 | $49.3M | $13.8M |
| Q4 25 | $13.5M | $-108.1M | ||
| Q3 25 | $12.2M | $-162.3M | ||
| Q2 25 | $11.6M | $-171.9M | ||
| Q1 25 | $10.1M | $-202.5M | ||
| Q4 24 | $10.5M | $-178.9M | ||
| Q3 24 | $11.2M | $-95.8M | ||
| Q2 24 | $13.5M | $-97.5M | ||
| Q1 24 | $13.2M | $-91.4M |
| Q4 25 | 58.6% | 59.8% | ||
| Q3 25 | 56.6% | -183.8% | ||
| Q2 25 | 52.8% | -4.9% | ||
| Q1 25 | 57.2% | -48.0% | ||
| Q4 24 | 57.0% | -181.4% | ||
| Q3 24 | 55.9% | 53.7% | ||
| Q2 24 | 55.3% | 36.2% | ||
| Q1 24 | 53.8% | 19.1% |
| Q4 25 | 30.6% | -304.8% | ||
| Q3 25 | 27.7% | -3327.6% | ||
| Q2 25 | 23.8% | -916.8% | ||
| Q1 25 | 25.4% | -1297.9% | ||
| Q4 24 | 26.0% | -4042.4% | ||
| Q3 24 | 26.9% | -377.1% | ||
| Q2 24 | 27.7% | -697.4% | ||
| Q1 24 | 29.4% | -698.4% |
| Q4 25 | 28.0% | -304.2% | ||
| Q3 25 | 24.7% | -3135.3% | ||
| Q2 25 | 22.9% | -894.2% | ||
| Q1 25 | 23.0% | -1373.3% | ||
| Q4 24 | 24.4% | -3935.5% | ||
| Q3 24 | 25.4% | -367.5% | ||
| Q2 24 | 26.9% | -676.6% | ||
| Q1 24 | 26.8% | -662.4% |
| Q4 25 | $0.38 | $-0.17 | ||
| Q3 25 | $0.34 | $-0.36 | ||
| Q2 25 | $0.33 | $-0.41 | ||
| Q1 25 | $0.28 | $-0.50 | ||
| Q4 24 | $0.28 | $-0.56 | ||
| Q3 24 | $0.30 | $-0.34 | ||
| Q2 24 | $0.36 | $-0.40 | ||
| Q1 24 | $0.36 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.4M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $184.8M | $1.1B |
| 总资产 | $212.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $115.4M | $743.3M | ||
| Q3 25 | $105.8M | $659.8M | ||
| Q2 25 | $99.2M | $525.1M | ||
| Q1 25 | $89.3M | $500.5M | ||
| Q4 24 | $99.2M | $594.4M | ||
| Q3 24 | $91.3M | $427.6M | ||
| Q2 24 | $70.7M | $474.3M | ||
| Q1 24 | $60.9M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $184.8M | $1.1B | ||
| Q3 25 | $176.1M | $1.0B | ||
| Q2 25 | $168.6M | $919.1M | ||
| Q1 25 | $161.5M | $933.9M | ||
| Q4 24 | $174.2M | $1.0B | ||
| Q3 24 | $178.6M | $524.6M | ||
| Q2 24 | $178.9M | $584.4M | ||
| Q1 24 | $168.2M | $401.2M |
| Q4 25 | $212.8M | $1.5B | ||
| Q3 25 | $206.0M | $1.4B | ||
| Q2 25 | $198.1M | $1.3B | ||
| Q1 25 | $190.9M | $1.3B | ||
| Q4 24 | $202.7M | $1.4B | ||
| Q3 24 | $209.9M | $726.5M | ||
| Q2 24 | $207.8M | $775.9M | ||
| Q1 24 | $194.8M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $14.5M | $-47.3M |
| 自由现金流率自由现金流/营收 | 30.1% | -133.1% |
| 资本支出强度资本支出/营收 | 1.2% | 3.5% |
| 现金转化率经营现金流/净利润 | 1.12× | — |
| 过去12个月自由现金流最近4个季度 | $53.7M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $15.1M | $-46.1M | ||
| Q3 25 | $11.6M | $-117.4M | ||
| Q2 25 | $14.6M | $-76.4M | ||
| Q1 25 | $13.4M | $-132.0M | ||
| Q4 24 | $13.5M | $-115.4M | ||
| Q3 24 | $12.0M | $-59.2M | ||
| Q2 24 | $14.3M | $-82.2M | ||
| Q1 24 | $12.3M | $-102.3M |
| Q4 25 | $14.5M | $-47.3M | ||
| Q3 25 | $11.4M | $-117.6M | ||
| Q2 25 | $14.4M | $-79.6M | ||
| Q1 25 | $13.3M | $-133.8M | ||
| Q4 24 | $12.4M | $-116.7M | ||
| Q3 24 | $11.3M | $-63.8M | ||
| Q2 24 | $13.8M | $-83.4M | ||
| Q1 24 | $12.0M | $-109.0M |
| Q4 25 | 30.1% | -133.1% | ||
| Q3 25 | 23.3% | -2272.5% | ||
| Q2 25 | 28.4% | -413.9% | ||
| Q1 25 | 30.3% | -907.4% | ||
| Q4 24 | 28.8% | -2567.7% | ||
| Q3 24 | 25.8% | -244.6% | ||
| Q2 24 | 27.4% | -578.5% | ||
| Q1 24 | 24.3% | -789.9% |
| Q4 25 | 1.2% | 3.5% | ||
| Q3 25 | 0.4% | 4.7% | ||
| Q2 25 | 0.5% | 16.4% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 2.6% | 28.6% | ||
| Q3 24 | 1.5% | 17.5% | ||
| Q2 24 | 1.1% | 8.2% | ||
| Q1 24 | 0.7% | 48.2% |
| Q4 25 | 1.12× | — | ||
| Q3 25 | 0.96× | — | ||
| Q2 25 | 1.26× | — | ||
| Q1 25 | 1.32× | — | ||
| Q4 24 | 1.29× | — | ||
| Q3 24 | 1.08× | — | ||
| Q2 24 | 1.06× | — | ||
| Q1 24 | 0.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
